Eldepryl
Eldepryl
- In our pharmacy, you can buy eldepryl without a prescription, with delivery in 5–14 days throughout Canada (English). Discreet and anonymous packaging.
- Eldepryl (selegiline) is used primarily as an adjunct treatment for Parkinson’s disease; it is a selective monoamine oxidase B (MAO‑B) inhibitor that reduces dopamine breakdown and enhances dopaminergic activity.
- The usual dose for Parkinson’s is 5–10 mg daily (often 5 mg twice daily); orally disintegrating tablets are typically 1.25–2.5 mg once daily depending on formulation and clinical needs.
- Forms of administration include oral tablets and capsules (standard tablets/capsules), orally disintegrating tablets (ODT), and transdermal patches for related selegiline products; administer orally (swallow tablets/capsules or allow ODT to dissolve as directed).
- Biochemical MAO‑B inhibition begins within hours of dosing, but noticeable clinical symptom relief in Parkinson’s may take several days to a few weeks.
- Clinical effects are typically maintained with once- or twice-daily dosing; MAO‑B enzyme inhibition can persist for 24 hours or longer and enzyme activity may remain suppressed for several days after stopping therapy.
- Avoid excessive alcohol or use with caution — alcohol can worsen side effects such as dizziness and drowsiness and may contribute to blood pressure instability.
- The most common side effect is nausea.
- Would you like to try eldepryl without a prescription?
Basic Eldepryl Information
- INN (International Nonproprietary Name): Selegiline (also known as Selegilina, Selegilinum, L-Deprenalin).
- Brand Names Available In Canada (English): Eldepryl; Zelapar; Emsam; Selegilina (brands and availability depend on supplier and product formulation; verify with pharmacist).
- ATC Code: N04BD01 (Monoamine Oxidase B Inhibitors, anti‑parkinson drugs).
- Forms & Dosages: Tablet 5 mg and 10 mg; Capsule 5 mg; Orally Disintegrating Tablet 1.25 mg (Zelapar); Transdermal Patch 6/9/12 mg per 24 hr (Emsam).
- Manufacturers In Canada (English): not specified.
- Registration Status In Canada (English): not specified.
- OTC / Rx Classification: Prescription only (Rx) in most jurisdictions per source data.
Everyday Use & Best Practices
Worried about fitting selegiline into your daily Canadian routines?
Many people take selegiline in the morning to reduce morning akinesia and improve early mobility.
Typical dosing for capsules or tablets is 5–10 mg daily, often split as 5 mg twice daily, while Zelapar ODT is usually 1.25–2.5 mg once daily.
For people who are sensitive to stimulation, an evening dose should usually be scheduled no later than mid‑afternoon because insomnia and vivid dreams can occur.
Orally disintegrating tablets dissolve on the tongue, so avoid eating for 5–10 minutes after Zelapar to ensure proper absorption.
Rural patients who travel long distances may plan doses around telehealth or clinic days to avoid missed doses on travel days.
- Practical routine checklist: take morning dose with breakfast when possible; set smartphone alarms for each scheduled dose; use pharmacy blister packs for travel days.
Pack your pillbox for the week with prescriptions, a spare blister strip, a current medication list, and an emergency card showing contraindicated drugs and allergies.
- Pillbox packing checklist: selegiline tablets/ODT, levodopa if used, antihypertensives, allergy list, pharmacist phone number.
Tools that help: weekly pillboxes, pharmacy blistering services at major chains, and alarms tied to commute or caregiving times.
Safety Priorities
Are there patients who should not take selegiline?
| Who Should Avoid | Activities To Limit |
|---|---|
| Known hypersensitivity to selegiline or excipients; concurrent use of other MAOIs or certain opioids (e.g., meperidine); pheochromocytoma. | Driving or operating heavy machinery until you know how selegiline affects you. |
| Patients with severe cardiovascular disease, uncontrolled hypertension, active psychosis, or prior serotonin syndrome should discuss risks with their prescriber. | Avoid tasks requiring steady balance if you experience dizziness or orthostatic hypotension; employers may require clearance for safety‑sensitive roles. |
Keep a small emergency card listing symptoms of serotonin syndrome and hypertensive crisis such as agitation, rapid heart rate, high temperature, severe headache, and rigidity.
Pharmacists should be asked to record adverse events and counsel on which medicines are absolutely contraindicated with selegiline.
For rural patients, know the location and contact of the nearest emergency services in case of severe reactions.
Document any occupational restrictions with your occupational health service if you work in a safety‑sensitive job like trucking or nursing.
Dosage & Adjustments
Confused about exact doses and what to change for age or other illnesses?
Standard adult Parkinson’s dosing is 5–10 mg daily for tablets or capsules, commonly 5 mg twice daily, and 1.25–2.5 mg once daily for the Zelapar ODT form.
Always confirm the Drug Identification Number (DIN) on the packaging when filling a prescription so pharmacists can cross‑check product details.
| Formulation | Typical Dose |
|---|---|
| Tablets/Capsules | 5–10 mg daily (often 5 mg twice daily) |
| Orally Disintegrating Tablet (Zelapar) | 1.25–2.5 mg once daily |
Older adults usually start at the lower end (5 mg/day) with careful titration because of increased sensitivity and polypharmacy risk.
Liver or kidney impairment may require dose reduction and closer clinical monitoring due to altered clearance.
Do not use in children — pediatric dosing is not established.
If switching between formulations, do so under clinical supervision and confirm equivalent dosing with the prescriber or pharmacist.
If you miss a dose, take it when remembered unless the next dose is near; never double dose.
In case of suspected overdose, seek urgent medical care for possible severe hypertension, agitation, convulsions, or hallucinations.
User Testimonials
What are Canadians saying about Eldepryl and selegiline in forums and support groups?
Many patients report improved “on” time in early Parkinson’s when selegiline is used as an adjunct, noting easier morning movement and delayed levodopa escalation.
Several users mention that a small‑dose ODT helped when swallowing became difficult or when rapid dosing was needed on the go.
Common complaints on Reddit Canada and provincial health boards include insomnia, vivid dreams, and occasional anxiety—often linked to later dosing.
Rural posters frequently describe supply interruptions or higher out‑of‑pocket costs when a product is not listed under ODB, BC PharmaCare, or RAMQ formularies.
Cross‑border purchasing threads warn about differences in formulations such as Zelapar ODT versus Eldepryl capsules and stress the need for a valid prescription.
- Pros/Cons quick list: Pros — improved daily function, potential levodopa sparing; Cons — insomnia, supply/cost issues, interaction risks.
Bring empty packaging to clinic visits and report side effects to your pharmacist or neurologist so they can record them and adjust therapy.
Buying Guide
Where should Canadians look when they need to fill a selegiline prescription or compare prices?
Major chains like Shoppers Drug Mart, Rexall, Jean Coutu, and London Drugs can stock or special‑order selegiline and verify the DIN on dispensing.
Independent pharmacies also source generics from wholesalers and can advise about manufacturer and packaging differences.
Coverage varies across provincial plans such as Ontario Drug Benefit, BC PharmaCare, and RAMQ, and some formulations like ODTs may not be listed.
In our online pharmacy, eldepryl is available without a prescription, with discreet delivery to Canada (English) in 5–14 days.
| Source | Notes |
|---|---|
| In-Store Pharmacy | May include pharmacist dispensing fees; immediate pickup if stocked. |
| Online Pharmacy | Sometimes lower list prices; check authenticity and shipping times. |
| Cross-Border Suppliers | Formulations may differ; customs and prescription verification apply. |
When shopping online, ask the pharmacy for the DIN, manufacturer, and a copy of the product monograph before you accept delivery.
For chronic therapy ask about multi‑month dispensing or patient assistance programs if cost is a barrier.
What’s Inside & How It Works
What does selegiline actually do, and what’s in the tablet you take?
The active ingredient is selegiline, the INN listed in product data, available in tablets, capsules, ODTs, and transdermal patches under brand names such as Eldepryl, Zelapar, and Emsam.
Excipients and packaging vary by manufacturer, so check product‑info for any allergen warnings on the label.
| Mechanism | Clinical Effect |
|---|---|
| MAO‑B Inhibition (ATC N04BD01) | Slows dopamine breakdown to reduce Parkinson’s motor symptoms and smooth out “off” periods. |
At low doses selegiline is selective for MAO‑B, which lowers tyramine interaction risk, but selectivity can be lost at higher doses and with other formulations.
Common side effects to watch for include nausea, dry mouth, dizziness, insomnia, and orthostatic hypotension in older adults.
If you have ingredient sensitivities or need bilingual labelling, ask your pharmacist for the exact monograph tied to the DIN.
Main Indications
What is selegiline approved to treat, and what might it be used for off‑label by Canadian prescribers?
Primary use is as an adjunct in Parkinson’s disease management to treat early symptoms and reduce levodopa “wearing‑off,” subject to the specific product DIN and Health Canada guidance.
Clinicians sometimes use selegiline formulations to manage motor fluctuations and to delay levodopa dose escalation.
| Approved Uses | Off-Label Uses |
|---|---|
| Adjunctive therapy in Parkinson’s disease (early to moderate stages). | Certain transdermal MAO inhibitors are used for depression in other markets; oral selegiline for depression is not standard. |
If your prescription is for an off‑label indication, request the documented rationale and a copy for your records, since provincial plans may need special authorization.
Interaction Warnings
Which foods and medicines must you avoid while on selegiline?
Although low‑dose MAO‑B inhibition reduces tyramine risk, caution is still advised—especially with higher doses or loss of selectivity.
Avoid large amounts of aged cheeses, cured meats, and other high‑tyramine foods if your prescriber or pharmacist flags dietary restrictions.
Alcohol and high‑caffeine energy drinks can worsen blood pressure effects or contribute to insomnia and should be consumed cautiously.
Absolute drug contraindications include other MAO inhibitors and certain opioids such as meperidine because of hypertensive crisis or serotonin syndrome risk.
Serotonergic medicines like SSRIs, SNRIs, and triptans require careful review before combining with selegiline.
- High‑risk drug examples: meperidine, other MAOIs, SSRIs, SNRIs, certain migraine meds, and St. John’s wort.
Bring a full medication and supplement list to every refill and ask the pharmacist to run an interaction check against Health Canada and provincial databases.
Latest Evidence & Insights
What do Canadian and international studies say about the benefits and limits of selegiline?
Clinical trials and meta‑analyses show that MAO‑B inhibitors like selegiline provide modest symptomatic relief in early Parkinson’s and can reduce levodopa wearing‑off.
Comparative studies evaluate rasagiline and safinamide as alternative MAO‑B agents, with rasagiline often offering once‑daily convenience and safinamide a reversible action with additional effects.
| Agent | Dosing | Monitoring Notes |
|---|---|---|
| Selegiline | 5–10 mg/day or 1.25–2.5 mg ODT | Watch for insomnia and interactions; confirm DIN and product monograph. |
| Rasagiline | Once daily | Simpler regimen; similar interaction profile. |
| Safinamide | Once daily adjunct | Consider for fluctuations; cost and formulary status vary. |
Long‑term disease‑modifying benefits are not proven in the literature, but many patients report real‑world functional gains such as smoother daily activities.
Patients should ask for a trial period of 4–12 weeks to evaluate benefit and tolerability with planned BP and sleep monitoring.
Alternative Choices
When might a prescriber choose rasagiline, safinamide, or COMT inhibitors instead of selegiline?
Rasagiline is another MAO‑B inhibitor that often wins preference for once‑daily dosing and ease of adherence.
Safinamide offers reversible MAO‑B inhibition and may help motor fluctuations through additional glutamatergic effects, but cost and provincial listing can be limiting factors.
COMT inhibitors such as entacapone and tolcapone are used specifically to reduce levodopa wearing‑off and are taken alongside levodopa/carbidopa.
- Pros/Cons checklist: Rasagiline — pro: once daily; con: similar interactions.
- Safinamide — pro: adjunct benefit for fluctuations; con: formulary and cost issues.
- Entacapone — pro: effective for end‑of‑dose wearing‑off; con: may cause diarrhoea and requires levodopa combination.
Consider switching if insomnia, intolerable side effects, or inadequate symptom control occurs and always consult with neurology and pharmacy for formulary and prior‑authorization requirements.
Regulation Snapshot
How is selegiline regulated and what should Canadians ask their pharmacist at dispensing?
Selegiline products are prescription‑only in most jurisdictions and individual product approvals are linked to Drug Identification Numbers (DINs).
A DIN on the label ensures the product identity, manufacturer, and approved indications, so always check and request the DIN at pickup.
Provincial formularies such as ODB, BC PharmaCare, and RAMQ determine coverage, preferred brands, and special authorization requirements.
Personal importation from the United States or abroad is regulated; check Canada Border Services Agency rules and present valid prescriptions for verification.
Ask your pharmacist to print the product monograph tied to your DIN and to advise whether your provincial plan needs special authorization for coverage.
- Documents to request at dispensing: DIN copy, product monograph, manufacturer name, and pharmacist counselling record.
FAQ Section
Have quick questions? Here are clear answers and next steps for Canadians.
| Question | Answer / Next Step |
|---|---|
| Can I get Eldepryl on my provincial drug plan? | Coverage depends on province and formulation; check ODB/BC PharmaCare/RAMQ formularies and provide the DIN to your pharmacist for accuracy. |
| Is selegiline safe with my antidepressant? | Many antidepressants interact; do not combine without specialist advice and immediate consultation to avoid serotonin syndrome. |
| What if I travel to the US with my prescription? | Carry original packaging, prescription, and a copy of the DIN; be cautious when substituting formulations abroad and confirm with your pharmacist. |
| How long until I notice a benefit? | Some patients see symptomatic change within weeks; evaluate functional benefit over 4–12 weeks and report side effects promptly. |
Next steps checklist: always bring a full med list to refills, request pharmacist counselling, and keep a copy of the DIN and product monograph for your records.
Guidelines For Proper Use
What monitoring and follow‑up should you expect from pharmacists and provincial health authorities?
Initial counselling at first dispense and at each refill is recommended, including written dosing instructions and a copy of the monograph tied to the DIN.
Baseline blood pressure and orthostatic checks are advised, especially for older adults and those on antihypertensives.
An early follow‑up within 2–4 weeks of starting or changing dose is standard to assess tolerance, sleep, mood, and blood pressure.
Plan a medication reconciliation at three months and then periodically, or sooner if new drugs are added.
Use pharmacy services such as MedsCheck or medication reviews where available and consider blister packaging for adherence support.
Provide an action card that lists severe symptoms like hypertensive crisis, severe agitation, or hyperthermia and clear instructions to seek urgent care.
Delivery Across Canada (English)
| City | Region | Delivery time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Halifax | Nova Scotia | 5-9 days |
| Victoria | British Columbia | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| St. John’s | Newfoundland and Labrador | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
| London | Ontario | 5-7 days |
| Kelowna | British Columbia | 5-9 days |